Sorry but the trials are completely separate. They have different drugs and different recruitment centres. Recruitment was completed for the Eyelea trial in February. I don't see any reason at all to suppose that the results would be withheld until another trial was completed. The ASX rules on continuous disclosure prohibit it.
- Forums
- ASX - By Stock
- OPT
- Opthea shares target raised on trial progress
Opthea shares target raised on trial progress, page-25
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
37.3¢ |
Change
0.008(2.05%) |
Mkt cap ! $414.7M |
Open | High | Low | Value | Volume |
36.5¢ | 38.5¢ | 36.0¢ | $541.7K | 1.437M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 125544 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 101696 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 124168 | 0.370 |
12 | 165337 | 0.365 |
7 | 193595 | 0.360 |
6 | 257858 | 0.355 |
10 | 252372 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 71914 | 11 |
0.380 | 153355 | 9 |
0.385 | 34243 | 4 |
0.390 | 44097 | 7 |
0.395 | 95385 | 6 |
Last trade - 15.21pm 12/07/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |